Cargando…

TRAIL-receptor 2—a novel negative regulator of p53

TNF-related apoptosis-inducing ligand (TRAIL) receptor 2 (TRAIL-R2) can induce apoptosis in cancer cells upon crosslinking by TRAIL. However, TRAIL-R2 is highly expressed by many cancers suggesting pro-tumor functions. Indeed, TRAIL/TRAIL-R2 also activate pro-inflammatory pathways enhancing tumor ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willms, Anna, Schupp, Hella, Poelker, Michelle, Adawy, Alshaimaa, Debus, Jan Frederik, Hartwig, Torsten, Krichel, Tim, Fritsch, Jürgen, Singh, Steven, Walczak, Henning, von Karstedt, Silvia, Schäfer, Heiner, Trauzold, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325694/ https://www.ncbi.nlm.nih.gov/pubmed/34333527 http://dx.doi.org/10.1038/s41419-021-04048-1

Ejemplares similares

TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
por: Mert, Ufuk, et al.
Publicado: (2019)

Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells
por: Willms, Anna, et al.
Publicado: (2019)

An unexpected turn of fortune: targeting TRAIL-Rs in KRAS-driven cancer
por: von Karstedt, Silvia, et al.
Publicado: (2020)

Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy
por: Kretz, Anna-Laura, et al.
Publicado: (2018)

Getting TRAIL back on track for cancer therapy
por: Lemke, J, et al.
Publicado: (2014)

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells
por: Tuthill, Mark H, et al.
Publicado: (2014)

The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2
por: Hartwig, Torsten, et al.
Publicado: (2017)

Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells
por: Hagelund, Sofie, et al.
Publicado: (2022)

Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells
por: Rambow, Anna-Christina, et al.
Publicado: (2022)

Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2
por: Bertsch, U, et al.
Publicado: (2014)

The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells
por: Legler, Karen, et al.
Publicado: (2018)

Highlight report: Limits of prognostication of non-small cell lung cancer
por: Adawy, Alshaimaa
Publicado: (2017)

The linear ubiquitin chain assembly complex regulates TRAIL‐induced gene activation and cell death
por: Lafont, Elodie, et al.
Publicado: (2017)

Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1
por: Lemke, J, et al.
Publicado: (2014)

TRAILblazing Strategies for Cancer Treatment
por: Kretz, Anna-Laura, et al.
Publicado: (2019)

TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells
por: Tawfik, Doaa, et al.
Publicado: (2019)

Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC
por: Gundlach, Jan-Paul, et al.
Publicado: (2018)

TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells
por: Voigt, Susann, et al.
Publicado: (2014)

Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries
por: Montinaro, Antonella, et al.
Publicado: (2022)

Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family
por: Degli-Esposti, Mariapia A., et al.
Publicado: (1997)

Downregulation of TRAIL-Receptor 1 Increases TGFβ Type II Receptor Expression and TGFβ Signalling Via MicroRNA-370-3p in Pancreatic Cancer Cells
por: Radke, David I., et al.
Publicado: (2018)

TRAIL/NF-κB/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines
por: Geismann, Claudia, et al.
Publicado: (2018)

LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L
por: Taraborrelli, Lucia, et al.
Publicado: (2018)

The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection
por: Miarka, Lauritz, et al.
Publicado: (2019)

c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells
por: Geismann, C, et al.
Publicado: (2014)

Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells
por: Kolluri, Krishna Kalyan, et al.
Publicado: (2018)

Onto better TRAILs for cancer treatment
por: de Miguel, D, et al.
Publicado: (2016)

Enhancement of TRAIL-induced apoptosis by 5-fluorouracil requires activating Bax and p53 pathways in TRAIL-resistant lung cancers
por: Nazim, Uddin MD., et al.
Publicado: (2017)

Countering TRAIL Resistance in Melanoma
por: Eberle, Jürgen
Publicado: (2019)

LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation
por: Zinngrebe, Julia, et al.
Publicado: (2016)

Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression
por: Gundlach, Jan-Paul, et al.
Publicado: (2021)

TRAIL Dependent Fratricidal Killing of gp120 Primed Hepatocytes by HCV Core Expressing Hepatocytes
por: Rizza, Stacey A., et al.
Publicado: (2011)

p53 Functions in Adipose Tissue Metabolism and Homeostasis
por: Krstic, Jelena, et al.
Publicado: (2018)

Enhancer Clusters Drive Type I Interferon-Induced TRAIL Overexpression in Cancer, and Its Intracellular Protein Accumulation Fails to Induce Apoptosis
por: Di Benedetto, Carolina, et al.
Publicado: (2023)

Monocarboxylate Transporter-1 (MCT1)-Mediated Lactate Uptake Protects Pancreatic Adenocarcinoma Cells from Oxidative Stress during Glutamine Scarcity Thereby Promoting Resistance against Inhibitors of Glutamine Metabolism
por: Ammar, Nourhane, et al.
Publicado: (2023)

Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL
por: Meijer, A, et al.
Publicado: (2013)

TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model
por: Fritsche, Hendrik, et al.
Publicado: (2015)

TRAIL protein expression in breast cancer cells correlates with nuclear grade
por: Bilski, Adam, et al.
Publicado: (2010)

Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015)

TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
por: Singh, Harsimran D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gcg2slaal2e7v8bulumq534kkd